Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of Midkine in Cancer Drug Resistance: Regulators of Its Expression and Its Molecular Targeting

14 May 2023

Abstract excerpt

Molecules involved in drug resistance can be targeted for better therapeutic efficacies. Research on midkine (MDK) has escalated in the last few decades, which affirms a positive correlation between disease progression and MDK expression in most cancers and indicates its association with multi-drug resistance in cancer. MDK, a secretory cytokine found in blood, can be exploited as a potent biomarker for the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chemokine receptors and signaling
Share to Glycosylation and Glycoproteins Research
Share to Proteoglycans and glycosaminoglycans research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37240085
DOI: 10.3390/ijms24108739

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of Midkine in Cancer Drug Resistance: Regulators of Its Expression and Its Molecular TargetingPMID 37240085Read ↗

Midkine: A Cancer Biomarker Candidate and Innovative Therapeutic ApproachesSemantic proximity Read ↗

Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases.Semantic proximity Read ↗

Analysis of Expression Levels and Functions of MDK and PTN Genes in Colorectal CancerSemantic proximity Read ↗

Abnormal expression, highly efficient detection and novel truncations of midkine in human tumors, cancers and cell lines.Semantic proximity Read ↗

The Role and Regulation of the NKG2D/NKG2D Ligand System in CancerSemantic proximity Read ↗

NKG2D Ligands–Critical Targets for Cancer Immune Escape and TherapySemantic proximity Read ↗

Mitochondrial signatures shape phenotype switching and apoptosis in response to PLK1 inhibitors.Semantic proximity Read ↗

Exosomes released by imatinib‑resistant K562 cells contain specific membrane markers, IFITM3, CD146 and CD36 and increase the survival of imatinib‑sensitive cells in the presence of imatinibSemantic proximity Read ↗

MED12 mutation induces RTK inhibitor resistance in NSCLC via MEK/ERK pathway activation by inflammatory cytokinesSemantic proximity Read ↗

Neuromedin U: a candidate biomarker and therapeutic target to predict and overcome resistance to HER-tyrosine kinase inhibitors.Semantic proximity Read ↗

Discrimination of the chemotherapy resistance status of human leukemia and glioblastoma cell lines by MALDI-TOF-MS profilingSemantic proximity Read ↗

Discovery of Two Targets of Dexmedetomidine in Breast CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.